Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatric Surgeon — Balance Foot & Ankle, Howell & Bloomfield Hills, MI. Last updated April 2026.

End-Stage Ankle Arthritis: Two Definitive Surgical Options

When conservative treatment for ankle arthritis fails to provide adequate relief, patients face a choice between two fundamentally different surgical approaches: total ankle replacement (arthroplasty) and ankle arthrodesis (fusion). Both procedures reliably eliminate arthritis pain, but they achieve this through opposite mechanisms—one preserves motion, the other eliminates it. Understanding how surgeons weigh the decision between these options helps patients engage more meaningfully in their own care planning.

Total Ankle Replacement (TAR): Preserving Motion

Modern total ankle replacement uses a three-component metal-and-polyethylene implant to resurface the tibiotalar joint, replacing worn cartilage while preserving ankle motion. Third-generation implant systems (INBONE, INFINITY, STAR, SALTO TALARIS) have demonstrated substantially improved 10-year survival rates compared to older designs, with contemporary literature reporting 85–90% implant survival at 10 years in appropriately selected patients.

TAR is best suited for patients who are older (typically 55+), have relatively normal ankle and hindfoot alignment, maintain good bone quality and stock, have a lower body mass index, and desire preserved ankle motion for daily activities and recreational pursuits. Patients with inflammatory arthritis (RA) often do particularly well with TAR because joint replacement addresses the systemic disease process without creating adjacent joint stress.

Ankle Arthrodesis (Fusion): Eliminating the Painful Joint

Ankle fusion involves removing remaining articular cartilage from the tibiotalar joint and securing the tibia, talus, and sometimes the fibula together with screws, plates, or an intramedullary nail until solid bony union occurs. The fused ankle is stable, pain-free, and capable of full weight-bearing—but ankle motion is permanently eliminated, shifting stress to adjacent hindfoot and midfoot joints over time.

Fusion is preferred for patients who are younger (under 50–55) with high activity demands, have significant deformity or bone loss that precludes implant placement, have poor bone quality (severe osteoporosis), are significantly overweight, have an active infection or avascular necrosis of the talus, or have peripheral neuropathy that increases implant failure risk. Fusion has a longer track record and is considered more durable under high-demand conditions.

Key Decision Factors Surgeons Weigh

Patient age and activity level are primary considerations. A 45-year-old construction worker who needs a durable pain-free ankle for 40+ years of demanding physical work is a better fusion candidate. A 65-year-old retiree who wants to walk for exercise and travel is an excellent TAR candidate. Deformity correction capacity also matters: modern TAR systems can correct mild-to-moderate deformity, but severe coronal plane deformity often requires fusion or staged osteotomy before replacement.

Bone quality assessed by CT or DEXA scan influences implant fixation potential. Avascular necrosis of the talus typically precludes TAR as the compromised blood supply prevents bony ingrowth into the talar component. Prior infection history is a relative contraindication to implant placement. Patient compliance with postoperative restrictions—particularly non-weight-bearing periods—also factors into the recommendation.

Outcomes and Long-Term Considerations

Well-performed ankle fusion achieves union in over 90% of cases and provides decades of reliable pain relief. The main long-term concern is progressive adjacent joint arthritis (subtalar and talonavicular joints) from compensatory motion, typically emerging 10–20 years postoperatively. TAR preserves more natural gait mechanics and reduces adjacent joint stress but carries risks of implant loosening, component subsidence, and the possibility of revision surgery—which is technically demanding and often requires conversion to fusion.

For most patients, the choice involves honest discussion about lifestyle priorities, realistic activity expectations, and the surgeon’s experience with both techniques. Consultation with a foot and ankle surgeon who performs high volumes of both procedures ensures the most balanced, individualized recommendation.

Ankle Replacement & Fusion Surgery in Michigan

Choosing between total ankle replacement and ankle fusion is one of the most important decisions for end-stage ankle arthritis. Dr. Tom Biernacki helps patients understand the benefits and trade-offs of each procedure based on their activity level, age, and goals.

Learn About Our Ankle Surgery Options | Book Your Appointment | Call (810) 206-1402

Clinical References

1. Haddad SL, et al. “Intermediate and long-term outcomes of total ankle arthroplasty and ankle arthrodesis.” J Bone Joint Surg Am. 2007;89(9):1899-1905.
2. Saltzman CL, et al. “Prospective controlled trial of STAR total ankle replacement versus ankle fusion.” J Bone Joint Surg Am. 2009;91(7):1611-1620.
3. Glazebrook M, et al. “Comparison of health-related quality of life between patients with end-stage ankle and hip arthrosis.” J Bone Joint Surg Am. 2008;90(3):499-505.

Your Board-Certified Podiatrists

Dr. Tom Biernacki, DPM

Board-Certified · FACFAS

Dr. Carl Jay, DPM

Board-Certified Podiatrist

Dr. Daria Gutkin, DPM

Podiatrist

Dr. Tom Biernacki, DPM

Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.